About
Patient Care
Education
Research
Community
May 13, 2024 | UCI Beall Applied Innovation
Henry Klassen, M.D., Ph.D. Awarded Entrepreneurial Leader of the Year
Henry Klassen, M.D., Ph.D. Professor of Ophthalmology and Director of the Stem Cell & Retinal Regeneration, UCI School of Medicine, wins the Entrepreneurial Leader of the Year. UCI Beall Applied Innovation, with generous support from Don and Ken Beall, created the annual UCI Innovator Awards to recognize UCI researchers working actively to promote commercialization of university intellectual property, which supports industry growth and moves inventions from the lab to market to benefit humankind.
May 07, 2024 | Visgenx
ELOVL2 Enzyme Product Improves Retinal Function and Rejuvenates Retina Architecture in an Aged Mouse Model of AMD
The study, performed in the lab of Dr. Dorota Skowronska-Krawczyk at the University of California, Irvine, confirms the critical nature of the ELOVL2 enzyme.
Feb 22, 2024 | UCI News
UC Irvine study shows similarities and differences in human and insect vision formation
Discovery offers insights into retinal disease origins and potential therapeutic targets.
Matt Miller Director, Communications and Public Relations mrmille2@uci.edu
Michelle Strombeck Manager, Communications and Public Relations 312-498-8208 mstrombe@hs.uci.edu
Stay Connected
Cyclist feared he would lose his eyesight and his livelihood following an incomplete surgery. He would then be referred to UCI Health's Gavin Herbert Eye Institute where he met cornea specialist, Soroosh Behshad, MD. A few days later Dr. Behshad performed a complex surgery to remove the cataract, and the cyclist now has 20/20 vision.
Following the UCI Office of Research’s official announcement last week that the Center for Translational Vision Research (CTVR) has achieved the prestigious Organized Research Unit (ORU) status at UCI, I want to thank everyone involved in working over the last five years to reach this significant milestone.
The Roger Steinert, MD, Legacy Award is a testament to leadership, dedication and expertise in the field
Sep 06, 2024 | Ophthalmology Times Europe
Magnetic cell therapy for corneal endothelial dysfunction
At the American Society of Cataract and Refractive Surgery annual meeting in Boston, Sumit Garg, MD, presented promising data from a phase 1 multicenter study indicating that magnetic cell delivery of human corneal endothelial cells (HCECs) to the anterior chamber is emerging as a safe and innovative cell-based treatment. The approach is showing early signs of efficacy in addressing corneal endothelial cell dysfunction, offering a potential breakthrough in treating conditions like Fuchs dystrophy and pseudophakic bullous keratopathy.
Aug 22, 2024 | UCI Health Gavin Herbert Eye Institute Shine the Light
Help for thyroid eye disease
Thyroid eye disease is an autoimmune condition that inflames the tissues around the eyes, potentially causing dryness, redness, double vision, difficulty closing the eyelids, and noticeable eye bulging. Oculoplastic specialists Dr. Lilangi Ediriwickrema and Dr. Jeremiah Tao share advanced treatment options available for patients with this condition.